Adrienne Choksi, MD
Department of Dermatology, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2007 | The University of Oklahoma College of Medicine, Oklahoma City, OK, US, MD |
| 2003 | The University of Texas at Austin, Austin, TX, US, BA |
Postgraduate Training
| 2008-2011 | Clinical Resident, Dermatology, The University of Michigan, Ann Arbor, MI |
| 2007-2008 | Clinical Intern, The University of Michigan, Ann Arbor, MI |
Licenses & Certifications
| 2025 | Basic Life Support |
| 2014 | Texas Medical Board |
| null | Certification |
| null | Certification |
| null | License |
Experience & Service
Other Professional Positions
Clinical Specialist, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2023 - Present
General Dermatologist, The Center for ENT, Houston, Texas, 2021 - 2023
General Dermatologist, DermSurgery Associates, Houston, Texas, 2017 - 2021
Assistant Professor, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2017
Staff Physician, Henry Ford Health System, Detroit, Michigan, 2011 - 2014
Honors & Awards
| 2020 - 2022 | Top Doctor Award, Houstonia Magazine |
| 2013 | E.A. Krull, MD Annual Faculty Role Model, Resident Educator of the Year, Henry Ford Department of Dermatology |
| 2009 - 2010 | Academic Chief Resident, University of Michigan Department of Dermatology |
| 2007 | Alpha Omega Alpha, The University of Oklahoma College of Medicine |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2015. "Update on Melanoma: Staging, Workup and Novel Therapies:. Invited. Oklahoma State Dermatology Society Annual Meeting. Houston, Texas, US.
- 2013. "Dermatologic Society Annual Meeting. Invited. Detroit, Michigan, US.
- 2012. “Digital Mole Monitoring and the Two-Step Method of Digital Follow-Up”. Invited. Michigan Dermatologic Society Annual Meeting. Detroit, Michigan, US.
Selected Publications
Peer-Reviewed Articles
- Lin J, Shaymaa H, Phyu P, Privadharsini N, Fiorinda M, Choksi A, Ciurea A, Nelson K, Doina I, Cabala-Torres C, Prieto V, Curry J. Dermatologic toxicities associated with novel pan-RAS/RAF inhibitors. J Cutan Pathol, 2026. PMID: 42244177.
- Yao C, Choksi AN, McLain PM. Paraneoplastic plaque-like cutaneous mucinosis in a patient with lung adenocarcinoma. J Cutan Pathol 45(4):305-307, 2018. e-Pub 2018. PMID: 29405349.
- Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. J Cutan Pathol 44(12):1080-1086, 2017. e-Pub 2017. PMID: 28901560.
- Jenkinson HA, Siroy AE, Choksi A. Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma. J Drugs Dermatol 16(10):1050-1052, 2017. e-Pub 2017. PMID: 29036262.
- Choksi AN, Orringer JS. Linear morphea-induced atrophy treated with hyaluronic acid filler injections. Dermatol Surg 37(6):880-3, 2011. e-Pub 2011. PMID: 21605257.
Review Articles
- Choksi AN, Poonawalla T, Wilkerson MG. Nanoparticles: a closer look at their dermal effects. J Drugs Dermatol 9(5):475-81, 2010. e-Pub 2010. PMID: 20480790.
- Thurston A, Grau RH. An update on the dermatoses of pregnancy. J Okla State Med Assoc 101(1):7-11, 2008. e-Pub 2008. PMID: 18390233.
Abstracts
- Choksi A. Systemic anaplastic large cell lymphoma with unbalanced DUSP22 gene rearrangement exclusively involving the skin. Submitted to Cutaneous Lymphoma World Congress 12/2023.
Patient Reviews
CV information above last modified October 20, 2026